David Maloney, MD, PhD
Enriched profileProfessor Emeritus, Translational Science and Therapeutics Division · Fred Hutchinson Cancer Center
David Maloney is Professor Emeritus, Translational Science and Therapeutics Division at Fred Hutchinson Cancer Center. OpenAlex indexes 843 publications with 54,034 citations (h-index 111); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory. Clarivate lists David Maloney as a Highly Cited Researcher (Clinical Medicine, 2025; Cross-Field, 2022-2024).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Maloney is Professor Emeritus, Translational Science and Therapeutics Division at Fred Hutchinson Cancer Center. The public record shows 843 publications with 54,034 citations (h-index 111), centered on CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (1997–2018).
- Most recent indexed publication: 2025 · Clinical cancer research
- Top research focus: CAR-T cell therapy research
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 362.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Sponsor: Fred Hutchinson Cancer Center
- Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Sponsor: Fred Hutchinson Cancer Center
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202510 payments$15,630openpaymentsdata.cms.gov ↗
- Celgene CorporationProgram year202516 payments$13,824openpaymentsdata.cms.gov ↗
- Celgene CorporationProgram year20248 payments$10,039openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
57.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor57.1%Acyclovir100%Part D<11 patientsCancer & immunology
42.9%Kinase inhibitor42.9%Imbruvica100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 1997–2018 per NIH RePORTER. The latest:
- Novel therapeutic for treatment of type 1 diabetes
Veralox Therapeutics, Inc
FY2020$300,000R41DK122917 - Development of a 12-LOX inhibitor for heparin induced thrombocytopenia and thrombosis
Veralox Therapeutics, Inc
FY2018$319,133R43HL144283 - Project 3: Stem Cell Allografts for Lymphoid Malignancies
Fred Hutchinson Cancer Research Center
FY2018$122,776P01CA078902
Congress activity
Updated 27 Aug 2026
127 congress contributions (2004–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:
- BASECAMP-1: An approach to improve patient screening efficiency and to provide large datasets for precision medicine clinical trials.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.
Clinical cancer research
Clinical Trial2025 - Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy.
Blood cancer discovery
Article2024 - Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
Blood advances
Clinical Trial2023 - Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma.
Leukemia & lymphoma
Article2022
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/David-G-Maloney-38866601
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/mshadman
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Internal Medicine internship/residency
Brigham and Women's Hospital, Boston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Medical Oncology Fellowship
Stanford University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Editorial & leadership roles
journal and society appointments- Member
American Society of Hematology (ASH)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Member
American Society for Transplantation and Cellular Therapy (ASBMT/ASTCT)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Member
American Association for Cancer Research (AACR)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Cross-Field202220232024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- Professor Emeritus of Medicine
Division of Hematology and Oncology, University of Washington
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hemonc.uw.edu ↗ - Medical Director of Cellular Immunotherapy
Immunotherapy Integrated Research Center (IIRC), Fred Hutchinson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - First medical director of the Bezos Family Immunotherapy Clinic
Seattle Cancer Care Alliance
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- Recurring video/commentary contributor
Cell & Gene Therapy Live (CGTLive)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgtlive.com ↗ - Interview subject
Patient Power (patient education video series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Brenda Sandmaier, MD
Fred Hutchinson Cancer Center
Lawrence Fong, MD
Fred Hutchinson Cancer Center
Michael Boeckh, MD
Fred Hutchinson Cancer Center